Precision diagnosis and treatment of PI3K/AKT/PTEN signaling pathway in HR-positive advanced breast cancer: perspectives from Chinese experts
{{output}}
For hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer (BC), the combinations of endocrine therapy (ET) and cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) are considered the standard first-line tr... ...
